In December, Howard Kaufman, MD, became the first director of the Rush University Cancer Center, which encompasses all of the cancer-related clinical, research and educational efforts at Rush. Kaufman came to Rush from Columbia University in New York City, where he was chief of the Division of Surgical Oncology and director of the Columbia Melanoma Center.
A native of Glenview, Ill., Kaufman received his Bachelor of Science degree from the University of Illinois at Chicago and his medical degree from Loyola University Chicago’s Stritch School of Medicine. He completed a residency in general surgery at Boston University Medical Center Hospital/Boston Medical Center and fellowships in tumor immunology and surgical oncology at the National Cancer Institute. Rush’s Kevin McKeough interviewed Kaufman recently about his plans for the future and the Rush University Cancer Center.
What are your responsibilities as director of the Rush University Cancer Center?
My goal is to develop a strategic vision for where we’re going, to bring people together and to align the research, clinical and educational missions as they pertain to cancer. In many institutions the cancer center coordinates the research activity, and there’s a service line that coordinates the clinical care, and they’re not always in alignment. One of the big advantages at Rush is that we are now aligning the two to make sure our clinical programs are developing in concert with our research programs. I have direct oversight of both of these functions. Continue reading